Literature DB >> 6870930

Mechanism of action of the nitrosoureas--V. Formation of O6-(2-fluoroethyl)guanine and its probable role in the crosslinking of deoxyribonucleic acid.

W P Tong, M C Kirk, D B Ludlum.   

Abstract

DNA which has been exposed to 2-haloethylnitrosoureas has been shown to contain the chemical crosslink 1-(N3-deoxycytidyl), 2-(N1-deoxyguanosinyl)-ethane [W. P. Tong, M. C. Kirk and D. B. Ludlum, Cancer Res. 43, 3102 (1982)]. We have hypothesized that this structure is formed by an initial attack of a 2-haloethyl group on the 6 position of guanine followed by an intramolecular rearrangement and secondary crosslinking reaction with cytosine. We have now shown that DNA which had been reacted with N-(2-fluoroethyl)-N'-cyclohexyl-N-nitrosourea contained O6-(2-fluoroethyl)guanine and have thus demonstrated that the first step in the proposed mechanism occurs. Furthermore, O6-(2-fluoroethyl)guanosine hydrolyzed to N1-(2-hydroxyethyl)guanosine, showing that the necessary intramolecular rearrangement occurs. These two observations greatly strengthen the proposed route to DNA crosslinking by the 2-haloethylnitrosoureas.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6870930     DOI: 10.1016/0006-2952(83)90420-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  Evidence that covalent complex formation between BCNU-treated oligonucleotides and E. coli alkyltransferases requires the O6-alkylguanine function.

Authors:  P E Gonzaga; L Harris; G P Margison; T P Brent
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

2.  Affinity purification and characterization of human O6-alkylguanine-DNA alkyltransferase complexed with BCNU-treated, synthetic oligonucleotide.

Authors:  P E Gonzaga; T P Brent
Journal:  Nucleic Acids Res       Date:  1989-08-25       Impact factor: 16.971

3.  DNA-mediated transfer and expression of a human DNA repair gene that demethylates O6-methylguanine.

Authors:  R Ding; K Ghosh; A Eastman; E Bresnick
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

4.  Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents.

Authors:  M E Dolan; R C Moschel; A E Pegg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

5.  Mechanism-based design of agents that selectively target drug-resistant glioma.

Authors:  Kingson Lin; Susan E Gueble; Ranjini K Sundaram; Eric D Huseman; Ranjit S Bindra; Seth B Herzon
Journal:  Science       Date:  2022-07-28       Impact factor: 63.714

6.  O6-Alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea.

Authors:  T P Brent; P J Houghton; J A Houghton
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

7.  Interrelationship between O6-alkylguanine-DNA alkyltransferase activity and susceptibility to chloroethylnitrosoureas in several glioma cell lines.

Authors:  T Hotta; Y Saito; T Mikami; K Kurisu; K Kiya; T Uozumi; G Isowa; K Ishizaki; M Ikenaga
Journal:  J Neurooncol       Date:  1993-07       Impact factor: 4.130

8.  Phosphotriester formation by the haloethylnitrosoureas and repair of these lesions by E. coli BS21 extracts.

Authors:  C A Carter; M C Kirk; D B Ludlum
Journal:  Nucleic Acids Res       Date:  1988-06-24       Impact factor: 16.971

9.  Repair of O6-(2-chloroethyl)guanine mediates the biological effects of chloroethylnitrosoureas.

Authors:  W J Bodell; T Aida; M S Berger; M L Rosenblum
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

10.  Enhancement by O6-benzyl-N2-acetylguanosine of N'-[2-chloroethyl]-N-[2-(methylsulphonyl)ethyl]-N'-nitrosourea therapeutic index on nude mice bearing resistant human melanoma.

Authors:  E Debiton; C Cussac-Buchdhal; E Mounetou; M Rapp; J M Dupuy; J C Maurizis; A Veyre; J C Madelmont
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.